Dylan Field sold $15M of FIG
President & CEO at Figma, Inc.. 486,930 shares at an average of $30.79, traded Feb 26, 2026, filed Mar 2, 2026.
Score components
- +25RoleCEO
- +25Trade size$15.0M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -30.3%, 3m -7.4%, 6m -6.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002073586-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | CConversion Class A Common Stock10b5-1 | +250,000 | $0.00 | $0 | 250,000 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -237,713 | $30.76 | $7.3M | 12,287 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -12,287 | $31.48 | $387k | 0 | Mar 2, 2026 |
| Feb 26, 2026 | CConversion Class A Common Stockindirect: By Trust10b5-1 | +62,500 | $0.00 | $0 | 62,500 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -59,430 | $30.76 | $1.8M | 3,070 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -3,070 | $31.48 | $97k | 0 | Mar 2, 2026 |
| Feb 26, 2026 | CConversion Class A Common Stockindirect: By Trust10b5-1 | +174,430 | $0.00 | $0 | 174,430 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -117,617 | $30.30 | $3.6M | 56,813 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -33,177 | $31.44 | $1.0M | 23,636 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -23,636 | $32.15 | $760k | 0 | Mar 2, 2026 |
| Feb 26, 2026 | CConversion Class B Common Stockderivative10b5-1 | -250,000 | $0.00 | $0 | 35,397,434 | Mar 2, 2026 |
| Feb 26, 2026 | CConversion Class B Common Stockderivativeindirect: See footnote10b5-1 | -62,500 | $0.00 | $0 | 14,754,517 | Mar 2, 2026 |
| Feb 26, 2026 | CConversion Class B Common Stockderivativeindirect: By Trust10b5-1 | -174,430 | $0.00 | $0 | 523,289 | Mar 2, 2026 |
Related signals
Other insiders at Figma, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | Figma, Inc. | Tyler Herb Chief Accounting Officer | $31k 1,418 shares | -1% | |
| 20Weak | Figma, Inc. | Brendan Mulligan General Counsel and Secretary | $450k 20,701 shares | -3% | |
| 9Weak | Figma, Inc. | Tyler Herb Chief Accounting Officer | $37k 1,416 shares | -1% | |
| 33Weak | Figma, Inc. | Brendan Mulligan General Counsel and Secretary | $2.8M 109,106 shares | -15% | |
| 33Weak | Figma, Inc. | Brendan Mulligan General Counsel and Secretary | $6.3M 211,599 shares | -23% | |
| 10Weak | Figma, Inc. | Tyler Herb Chief Accounting Officer | $60k 2,000 shares | -1% | |
| 17Weak | Figma, Inc. | Tyler Herb Chief Accounting Officer | $50k 1,840 shares | -1% | |
| 41Moderate | Figma, Inc. | Index Ventures VI (Jersey) LP owner | $317k 12,475 shares | -2% | |
| 44Moderate | Figma, Inc. | Daniel H. Rimer director | $317k 12,475 shares | -2% | |
| 10Weak | Figma, Inc. | Tyler Herb Chief Accounting Officer | $18k 709 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.